IPO + Airbnb + C19 Vaccines – All Part of an Interesting Equation
Thursday will see Airbnb's long-awaited IPO on Nasdaq.
The company that helped to pioneer the sharing economy has had an interesting pandemic season – including being the object of class-action lawsuits, returning up to $250m in fees and laying off 25% of its workforce.
Now, however, the timing of its IPO looks near-perfect with respect to the approval and application of Covid vaccines.
One positive of the pandemic for the company has been an increase in longer term rentals, with customers booking homes in exotic locations for weeks or months at a time in order to work from home.
Now, the vaccines should reopen Airbnb's traditional vacation market and give a boost to its new 'Experiences' product line. But there are headwinds too, like the prospect of increased regulation and Google's entry into the market.
Invest With Admiral Markets
With an Invest.MT5 account from Admiral Markets, you can buy stocks and Exchange-Traded Funds (ETFs) from 16 of the world's largest stock exchanges!
Benefits include being able to open an account with a minimum deposit of just €1, receiving free real-time market data and analysis and using the world renowned MetaTrader 5 multi-asset trading platform! Click the banner below to open an account today!
INFORMATION ABOUT ANALYTICAL MATERIALS:
The given data provides additional information regarding all analysis, estimates, prognosis, forecasts, market reviews, weekly outlooks or other similar assessments or information (hereinafter "Analysis") published on the website of Admiral Markets. Before making any investment decisions please pay close attention to the following:
1.This is a marketing communication. The content is published for informative purposes only and is in no way to be construed as investment advice or recommendation. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and that it is not subject to any prohibition on dealing ahead of the dissemination of investment research.
2.Any investment decision is made by each client alone whereas Admiral Markets UK Ltd (Admiral Markets) shall not be responsible for any loss or damage arising from any such decision, whether or not based on the content.
3.With a view to protecting the interests of our clients and the objectivity of the Analysis, Admiral Markets has established relevant internal procedures for prevention and management of conflicts of interest.
4.The Analysis is prepared by an independent analyst Roberto Rivero, Freelance Contributor (hereinafter "Author") based on personal estimations.
5.Whilst every reasonable effort is taken to ensure that all sources of the content are reliable and that all information is presented, as much as possible, in an understandable, timely, precise and complete manner, Admiral Markets does not guarantee the accuracy or completeness of any information contained within the Analysis.
6.Any kind of past or modelled performance of financial instruments indicated within the content should not be construed as an express or implied promise, guarantee or implication by Admiral Markets for any future performance. The value of the financial instrument may both increase and decrease and the preservation of the asset value is not guaranteed.
7.Leveraged products (including contracts for difference) are speculative in nature and may result in losses or profit. Before you start trading, please ensure that you fully understand the risks involved.